Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1069999/full |
_version_ | 1811187453181034496 |
---|---|
author | Ni Zhao Ye Yi Wen Cao Xiao Fu Nan Mei Chunli Li |
author_facet | Ni Zhao Ye Yi Wen Cao Xiao Fu Nan Mei Chunli Li |
author_sort | Ni Zhao |
collection | DOAJ |
first_indexed | 2024-04-11T14:03:44Z |
format | Article |
id | doaj.art-77183d308c52458cb5c03040a8ab581e |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-11T14:03:44Z |
publishDate | 2022-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-77183d308c52458cb5c03040a8ab581e2022-12-22T04:19:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10699991069999Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapyNi Zhao0Ye Yi1Wen Cao2Xiao Fu3Nan Mei4Chunli Li5Department of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, ChinaDepartment of Respiratory Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, ChinaDepartment of Hematology. The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2022.1069999/fullbiomarkerscytokinesimmunotherapylung cancerimmune related adverse events |
spellingShingle | Ni Zhao Ye Yi Wen Cao Xiao Fu Nan Mei Chunli Li Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy Frontiers in Oncology biomarkers cytokines immunotherapy lung cancer immune related adverse events |
title | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_full | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_fullStr | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_full_unstemmed | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_short | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_sort | corrigendum serum cytokine levels for predicting immune related adverse events and the clinical response in lung cancer treated with immunotherapy |
topic | biomarkers cytokines immunotherapy lung cancer immune related adverse events |
url | https://www.frontiersin.org/articles/10.3389/fonc.2022.1069999/full |
work_keys_str_mv | AT nizhao corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT yeyi corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT wencao corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT xiaofu corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT nanmei corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT chunlili corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy |